Format

Send to

Choose Destination
See comment in PubMed Commons below
Tuberculosis (Edinb). 2012 Mar;92 Suppl 1:S25-9. doi: 10.1016/S1472-9792(12)70009-4.

Rational approach to selection and clinical development of TB vaccine candidates.

Author information

1
Aeras, 1405 Research Boulevard, Rockville, MD 20850, USA. lbarker@aeras.org

Abstract

A rational process is clearly needed and can be extremely helpful for selection, assessing and advancing TB vaccine candidates from entry into preclinical and clinical development and for advancing candidates from early safety and immunogenicity clinical trials to proof-of-concept and pivotal efficacy trials. A joint effort between Aeras and the Tuberculosis Vaccine Initiative has focused on the development of objective criteria for a number of key general vaccine characteristics which can be assessed at critical stages of development. In order to maximize development efficiency, increase likelihood of success, and optimize use of scarce resources, this process includes establishment of gates for moving TB vaccine candidates through progressive development stages based on meeting the established criteria for specific vaccine candidates.

PMID:
22441156
DOI:
10.1016/S1472-9792(12)70009-4
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Support Center